Cite
HARVARD Citation
Wainberg, Z. et al. (n.d.). Interim results from the phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) in pancreatic cancer (PC), non-small cell lung cancer (NSCLC), and metastatic breast cancer (mBC). European journal of cancer. pp. S103-. [Online].